Treatment patterns and safety outcomes after splenectomy or thrombopoietin receptor agonists as second-line therapy for immune thrombocytopenia: Korean claims-based study
Publication date: October 2026 Source: Research and Practice in Thrombosis and Haemostasis, Volume 10, Issue 7 Author(s): Hyung-Jun Lim, Kunye Kwak, Changgon Kim, Yoon Seok Choi, Yong Park, Byung Soo Kim, Ki Hoon Ahn, Ka-Won Kang
Treatment patterns and safety outcomes after splenectomy or thrombopoietin receptor agonists as second-line therapy for immune thrombocytopenia: Korean claims-based study. // Research and Practice in Thrombosis and Haemostasis. – URL: https://www.sciencedirect.com/science/article/pii/S2475037926036502?dgcid=rss_sd_all
Treatment patterns and safety outcomes after splenectomy or thrombopoietin receptor agonists as second-line therapy for immune thrombocytopenia: Korean claims-based study. Research and Practice in Thrombosis and Haemostasis. https://www.sciencedirect.com/science/article/pii/S2475037926036502?dgcid=rss_sd_all
“Treatment patterns and safety outcomes after splenectomy or thrombopoietin receptor agonists as second-line therapy for immune thrombocytopenia: Korean claims-based study.” Research and Practice in Thrombosis and Haemostasis.
@article{article117632,
title = {Treatment patterns and safety outcomes after splenectomy or thrombopoietin receptor agonists as second-line therapy for immune thrombocytopenia: Korean claims-based study},
journal = {Research and Practice in Thrombosis and Haemostasis},
url = {https://www.sciencedirect.com/science/article/pii/S2475037926036502?dgcid=rss_sd_all}
}